OPINION: How probiotics research is taking us to the next level of understanding

By Marla Cunningham

- Last updated on GMT

 Marla Cunningham, technical innovation manager at Health World Ltd.
Marla Cunningham, technical innovation manager at Health World Ltd.

Related tags Probiotic

While clinicians are increasingly aware of the evidence behind specific probiotic strains for a variety of conditions, restoring balance to a microbiome disrupted by diet, medications or illness often remains an area of confusion, writes Health World Ltd’s Marla Cunningham.

Fortunately, however, research is revealing a new view of our microbiome and where probiotics fit into its restoration and maintenance.

Probiotics are not the same as commensal flora

One of the most important paradigm shifts in probiotic understanding is that they cannot be considered interchangeable with commensal flora. The human microbiome contains over 1000 species, with Lactobacilli​ and Bifidobacteria​, the two most common genera of probiotics, found to comprise only 5%. Commensals are seeded at birth and from ongoing human and environmental contact, with in-utero​ transmission to the foetus discovered recently. ​However, commensals can be disrupted, for example by highly processed prebiotic-deficient diets, stress, and use of medications such as antibiotics and proton pump inhibitors. 

Probiotics help repopulate the gut (but not the way you may think)

The latest research is supporting clinical experience, that despite constituting only a minority of the microbiome, supplementation with certain Lactobacilli​ and Bifidobacteria​ strains can be a highly effective therapy in situations of dysbiosis. However, rather than replacing commensal flora, specific probiotic strains are catalysts for the regrowth of disrupted species, producing metabolites that modify the growth or behaviour of other species, altering gut conditions (e.g. intestinal pH and nutrient availability) and by immune system interaction, all of which have a regulating effect on both pathogen and commensal growth. That said, these actions differ significantly between strains.

For example, Lactobacillus acidophilus​ (NCFM®) and Bifidobacterium lactis​ (Bi-07) have been shown to consume a wider range of prebiotic substrates in comparison to other strains – with the metabolites feeding neighbouring commensal strains. Other probiotic strains maintain gut mucosal health; up-regulating gene activity and expression of tight junction proteins (as found in studies utilising Lactobacillus rhamnosus​ GG [LGG®]).

Through these beneficial regulating actions on commensal flora, the immune system, and healthy gut function, probiotics are akin to policemen within the gut, required in regular small amounts to keep the peace amongst the larger number of commensal ‘citizens’.

The importance of correct probiotic care

Our understanding of probiotics has come a long way from the first studies of sour milk in the early 1900s to today’s convenient capsules. Nevertheless, despite impressive technological advances, probiotics remain live organisms, a fact with significant implications for probiotic storage and handling.

While traditional probiotic foods have a shelf life of only a few weeks, probiotic supplements today undergo specialised processes to prepare the microorganisms to survive much longer, up to 24 months or more in a capsule. The beneficial bacteria are grown in nutrient media in large numbers, and then processed by freeze-drying, to remove most of the water and induce a state of dormancy – characterised by negligible metabolic activity, whilst still maintaining future viability.

However, after freeze-drying, additional factors are essential to maintain viable microorganisms over the shelf life, with probiotics considered most stable when either temperature and/or moisture levels are controlled for. One way to achieve this is refrigeration. Another method is via the incorporation of moisture-controlling technologies, as moisture may be introduced from the capsule, the air in the bottle, or due to the water activity of the probiotic itself.

Molecular desiccants are a common method of reducing relative humidity levels, however may not be sufficient alonw to keep probiotics in a state of dormancy in warmer climates. For example, Zone IV, frequently hot and humid countries (common in the Asia-Pacific region) may be exposed to room temperatures that fluctuate and reach >25°C.

Other technologies include low-moisture capsules. However, used in isolation, these initiatives may also be insufficient against the reality of environmental conditions.  As such, a range of moisture-control technologies that protect against temperature and moisture fluctuations may be required in combination to preserve the viability of the probiotic organisms and ensure they remain efficacious. Furthermore, probiotics manufactured using a specialised humidity-controlled environment results in a reduction of water activity within the probiotic capsule itself, which improves their longevity.

Harnessing the power of probiotics

Probiotics provide a powerful catalyst for gut health and microbiome restoration, and indeed, many other systemic conditions, provided researched strains, doses and combinations are selected and handled correctly. Fortunately, as probiotic research expands, clinicians can expect to be equipped even more fully in this exciting area of health.

Marla has worked in retail pharmacy, professional education development, clinical trial management, and product development for Health World Ltd, an Australian supplier of probiotic products to pharmacies. Marla is extensively involved in conducting microbiome-related literature reviews, working closely with probiotic researchers and developing evidence-based probiotic products.

Probiota Asia 2017

Probiota Asia 2017 Master logo

The Probiota series is growing, and in October 2017, Singapore will host the first ever Probiota Asia event. Building on the success of the annual global Probiota and Probiota Americas events, Probiota Asia will focus exclusively on this high growth market and the challenges it faces.

Save the date: 11-13 October 2017

Related news

Related products

show more

Empowering Women Through the Life Cycle

Empowering Women Through the Life Cycle

Content provided by Glanbia Nutritionals | 07-Nov-2023 | Product Brochure

As discussions around female empowerment widen, and advances in women’s health access and provision accelerate, the implications for business, healthcare,...

Analyzing the unknown threat from Microplastics

Analyzing the unknown threat from Microplastics

Content provided by Agilent Technologies | 06-Nov-2023 | Infographic

Microplastics are any plastic-derived synthetic solid particle or polymeric matrix, ranging in size from 1 µm to 5 mm and insoluble in water.

Pycnogenol® Supports Cognitive Function

Pycnogenol® Supports Cognitive Function

Content provided by Horphag Research | 18-Sep-2023 | White Paper

Clinical research shows daily supplementation with Pycnogenol® may help support brain function in a variety of age groups with results showing improved...

Functional Beverage Market Insights in ASPAC

Functional Beverage Market Insights in ASPAC

Content provided by Glanbia Nutritionals | 06-Jul-2023 | Product Brochure

High growth ahead for protein beverages makes Asia Pacific (ASPAC) the market to watch. Consumer research shows new usage occasions, key consumption barriers,...

Related suppliers

Follow us

Products

View more

Webinars

Food & Beverage Trailblazers

F&B Trailblazers Podcast